Navigation Links
Blood pressure drugs may lengthen lives of melanoma patients
Date:9/20/2011

COLUMBUS, Ohio Beta-blocker drugs, commonly used to treat high blood pressure, may also play a major role in slowing the progression of certain serious cancers, based on a new study.

A review of thousands of medical records in the Danish Cancer Registry showed that patients with the skin cancer melanoma, and who also were taking a specific beta-blocker, had much lower mortality rates than did patients not taking the drug.

The report, published in the current issue of the journal Cancer Epidemiology, Biomarkers & Prevention, summarized the work of a team of researchers at Ohio State University's Institute for Behavioral Medicine Research (IBMR) and the Comprehensive Cancer Center.

If the results are confirmed in a planned clinical trial, this might be an additional adjunct treatment for cancer patients facing a poor prognosis.

At the center of this research is the fact that certain molecules that play important roles in the immune system also appear to promote both tumor growth and metastasis, the shedding and spreading of tumor tissue to other parts of the body.

"The work started with some earlier studies where we discovered that certain tumor cells had receptors to two specific catecholamine stress hormones epinephrine and norepinephrine," explained Ron Glaser, professor of molecular virology, immunology and medical genetics and director of the IBMR.

"When either of these hormones bind to the tumor cell receptors, it stimulates the production of vascular endothelial growth factor (VEGF), interleukin-8 (IL-8), interleukin-6 (IL-6) and certain matrix metalloproteins all molecules known to stimulate blood flow to tumors, enhancing their growth, and promoting metastasis."

The earlier studies first used tissue from a nasopharyngeal carcinoma cell line, and later from both multiple myeloma and melanoma cell lines. When treated with the beta-blocker propranol, all cells stopped producing the t
'/>"/>

Contact: Ronald Glaser
glaser.1@osu.edu
614-292-5526
Ohio State University
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Inflammatory Bowel Ups Risk for Blood Clots
2. Bowel disease link to blood clots
3. Local Blood Supply Impacted by Wednesdays Severe Snow Storm
4. PERSONALABS Offers Discounted Healthy Heart Online Blood Tests in February
5. China Cord Blood Corporation Warrant Registration Statement Declared Effective by SEC
6. NIH grants to Childrens Hospital will advance novel stem cell treatments for blood disorders
7. Bilberry Seems to Act Against Blood Sugar
8. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
9. UCR researcher identifies mechanism malaria parasite uses to spread in red blood cells
10. NHLBI, CDC launch surveillance and research program for inherited blood diseases
11. IOM report declares high blood pressure a neglected disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Applied PilotFish Healthcare Integration ... it has added support for the Direct Protocol to ... for Healthcare. In addition to the product’s already included ... and Web Services, it now offers support for the ... a specification of the Direct Project and ...
(Date:5/23/2013)... A new report estimates that ... could save $2.1 billion without reducing access or the ... that Florida and other state Medicaid programs could make ... rely on to curb wasteful pharmacy spending. , ... MedicaidPharmacySavings.com . , “The easiest way for Florida ...
(Date:5/23/2013)... of patients with high-risk neuroblastoma a common tumor that ... using tumor-killing cancer drugs. A study published by Cell ... & Biology reveals a new genomic approach to ... causing cancer cells to differentiate, or convert from immature ... method, the researchers identified a compound that causes neuroblastoma ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... by JD Media Surge, LLC. Targeting members of the ... services online and attract new patients, the consulting service ... Internet marketing strategies. , The medical Internet marketing agency ... struggling to get results online. As part of the ...
(Date:5/23/2013)... Traditionally, laser skin therapy has been used ... colour, this can be tricky. Based on the Fitzpatrick ... treated safely with most lasers. Darker skins, who are ... been left without recourse. Those who would most benefit ... successfully. , Hyperpigmentation occurs when there is ...
Breaking Medicine News(10 mins):Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2Health News:PCMA: Upgrading Medicaid Drug Benefits Could Save Florida $2.1 Billion 2Health News:New screening approach uncovers potential alternative drug therapies for neuroblastoma 2Health News:Healthcare Internet Marketing Consulting Services Launched by JD Media Surge 2Health News:Vancouver Skin Care Clinic Successfully Clears Pigmentation in Skin of Colour 2Health News:Vancouver Skin Care Clinic Successfully Clears Pigmentation in Skin of Colour 3
... you that already! Older adults are more ... shared or not shared information with, according to a new ... the kind of memory faux pas that can lead to ... doctor,s office. Ironically, after making these memory errors older adults ...
... HealthDay Reporter , MONDAY, Aug. 30 (HealthDay ... pain in patients with nerve pain stemming from injuries ... with chronic nerve pain were taught to take a ... pipe, three times a day, for five days. The ...
... Quebec, Australia and the United Kingdom by publicly ... CMAJ ( Canadian Medical Association Journal ) (pre-embargo ... million Canadians (19% of the population) currently use ... recent years. A 2009 review of studies indicates ...
... 30 August 2010 - The notion that cutting or ... difficult to understand for most people, but it is ... themselves. Individuals with borderline personality disorder experience ... regulation skills. This group of people also displays high ...
... heart rhythm disorder is resulting in an alarming number ... A research team led by Professor Prash Sanders, ... Centre at the Royal Adelaide Hospital, found that hospital ... in Australia over a 15-year period. These findings ...
... Elsevier, a world-leading publisher of scientific, technical ... the launch of SciVerse, an innovative platform that ... scientific community to collaborate on the development of ... to releasing the APIs (application programming interfaces) for ...
Cached Medicine News:Health News:Older adults experience 'destination amnesia' 2Health News:Smoked Marijuana May Ease Chronic Nerve Pain 2Health News:Smoked Marijuana May Ease Chronic Nerve Pain 3Health News:Hurts so good -- neural clues to the calming effects of self-harm 2Health News:Heart disorder hits national epidemic proportions 2Health News:Elsevier introduces SciVerse, an innovative platform for accelerating science 2
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, Inc., ... today that it will present new results on ... industry conference sponsored by the PML Consortium (composed ... JC polyomavirus (JCV) is the causative agent of ... kinase inhibitor in an extended release formulation, can ...
(Date:5/23/2013)... -- InspireMD, Inc. ("InspireMD" or the ... protection stents, today announced new 6-month results from ... trial demonstrating that the MGuard Embolic Protection Stent ... in all-cause mortality in ST segment elevation myocardial ... presented at the InspireMD STEMI Symposium at EuroPCR, ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
... Medical Alarm Concepts Holding, Inc. (OTC Bulletin Board: MDHI), manufacturer ... you to speak and listen directly through the pendant, announced today ... grocery stores. , , ... Under the terms of the distribution agreement signed in March of ...
... BEIJING , July 13 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems,Ltd. ... and sale of medical devices and homecare medical products in ... line,(QS-100A series) from Beijing Qiumanshi Technology Co., Ltd. The acquisition,includes the ... , , ...
Cached Medicine Technology:Medical Alarm Concepts™ Announces Roll-Out of the MediPendant™ at Albertsons 2Medical Alarm Concepts™ Announces Roll-Out of the MediPendant™ at Albertsons 3Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 2Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 3Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 4
... Precision Hand Instruments were developed in surgeon's ... while still having an instrument with the ... the fear of the bending or breaking. ... manufactured to conform to the surgeon's hand. ...
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
This optimal design addresses low-cost, simple, non-invasive ankle distraction....
... On-Site Simplicity with Clinical Lab ... be used as an accurate ... or breath tests. In clinical ... by the Q.E.D.® demonstrated high ...
Medicine Products: